Alpha Cognition Inc (ACOG) Price & Analysis

Compare

16 Followers

ACOG Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.75 - $13.00

Previous Close$5.43

Volume265.46K

Average Volume (3M)48.50K

Market Cap

$155.39M

Enterprise Value$18.34M

Total Cash (Recent Filing)$45.53M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta0.66

Next Earnings

Aug 14, 2025

EPS Estimate

-0.46

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding16,019,787

10 Day Avg. Volume54,447

30 Day Avg. Volume48,498

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.12

Enterprise Value/Revenue6.26

Enterprise Value/Gross Profit6.27

Enterprise Value/Ebitda-1.40

Forecast

1Y Price Target

$20.00

Price Target Upside106.19% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Market AdoptionOver 50% of prescribers have already written refill prescriptions for ZUNVEYL, indicating strong early adoption.

Regulatory ProgressChinese regulatory submission accepted for review by the National Medical Products Administration, potentially leading to approval next year.

Sales PerformanceAlpha Cognition's sales exceeded expectations, leading to an increase in sales forecasts for the upcoming years.

Bears Say

Market RisksRisks include inability to launch ZUNVEYL in an optimized or timely manner and slower-than-expected market uptake due to pricing pressures or competition.

Alpha Cognition Inc News

Alpha Cognition announces CMS Zunveyl NDA accepted for review by NMPA

Alpha Cognition (ACOG) announced China Medical System new drug application for Zunveyl has been accepted by the National...

16d ago

ACOG

Alpha Cognition files to sell 2.09M common shares for holders

17:31 EDT Alpha Cognition (ACOG) files to sell 2.09M common shares for holders Published first on TheFly –...

23d ago

ACOG

Alpha Cognition Inc’s Strategic Developments and Market Potential Drive Buy Rating

Alpha Cognition Inc, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju...

17d ago

ACOG

Promising Preclinical Data on ALPHA-1062 Supports Buy Rating for Alpha Cognition

Alpha Cognition Inc, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju...

1M ago

ACOG

Alpha Cognition shares preclinical data for TBI drug ALPHA-1062

Alpha Cognition (ACOG) announced preclinical data supporting the continued development of ALPHA-1062 for the treatment of mild traumatic...

1M ago

ACOG

Alpha Cognition files to sell 2.375M common shares for holders

The company will not receive any proceeds from the sale of common shares by the selling stockholders. Published...

1M ago

ACOG

Alpha Cognition Inc. Reports Strong Q1 2025 Performance

Alpha Cognition Inc ( ($ACOG) ) has released its Q1 earnings. Here is a breakdown of the information...

3M ago

ACOG

Alpha Cognition’s Earnings Call Highlights Success and Growth

Alpha Cognition Inc (($ACOG)) has held its Q1 earnings call. Read on for the main highlights of the...

3M ago

ACOG

Alpha Cognition’s Strong Financial Performance and Promising Alzheimer’s Treatment Drive Buy Rating

Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Alpha Cognition Inc (ACOG – Research Report),...

3M ago

ACOG

Alpha Cognition Inc. Reports Strong 2024 Financials

Alpha Cognition Inc ( ($ACOG) ) has released its Q4 earnings. Here is a breakdown of the information...

4M ago

ACOG

Alpha Cognition Earnings Call: Positive Outlook Amid Growth

Alpha Cognition Inc (($ACOG)) has held its Q4 earnings call. Read on for the main highlights of the...

4M ago

ACOG

Alpha Cognition commercially launches ZUNVEYL to treat mild to moderate AD

Alpha Cognition (ACOG) announced the official commercial launch of ZUNVEYL, a new treatment for mild to moderate Alzheimer’s...

5M ago

ACOG

Alpha Cognition initiated with a Buy at H.C. Wainwright

H.C. Wainwright initiated coverage of Alpha Cognition (ACOG) with a Buy rating and $20 price target Alpha is...

5M ago

ACOG

Alpha Cognition secures additional patent for Zunveyl from USPTO

Alpha Cognition (ACOG) announced that the United States Patent and Trademark Office has granted a new patent titled...

6M ago

ACOG

ACOG FAQ

What was Alpha Cognition Inc’s price range in the past 12 months?

Alpha Cognition Inc lowest stock price was $3.75 and its highest was $13.00 in the past 12 months.

What is Alpha Cognition Inc’s market cap?

Alpha Cognition Inc’s market cap is $155.39M.

When is Alpha Cognition Inc’s upcoming earnings report date?

Alpha Cognition Inc’s upcoming earnings report date is Aug 14, 2025 which is today.

How were Alpha Cognition Inc’s earnings last quarter?

Currently, no data Available

Is Alpha Cognition Inc overvalued?

According to Wall Street analysts Alpha Cognition Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alpha Cognition Inc pay dividends?

Alpha Cognition Inc does not currently pay dividends.

What is Alpha Cognition Inc’s EPS estimate?

Alpha Cognition Inc’s EPS estimate is -0.46.

How many shares outstanding does Alpha Cognition Inc have?

Alpha Cognition Inc has 16,019,787 shares outstanding.

What happened to Alpha Cognition Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Alpha Cognition Inc?

Currently, no hedge funds are holding shares in ACOG

Alpha Cognition Inc Stock Smart Score

Neutral

Fundamentals

Return on Equity

-56.79%

Trailing 12-Months

Asset Growth

1298.18%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alpha Cognition Inc

Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.

Alpha Cognition Inc (ACOG) Earnings & Revenues

Historic Earnings Reports

ACOG Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call conveyed a largely positive sentiment, highlighting a successful launch of ZUNVEYL, strong financial position with a debt-free balance sheet, and promising partnerships and patent developments. The positive aspects were slightly tempered by the ongoing operating loss and lack of revenue guidance, but these did not overshadow the overall positive outlook.View all ACOG earnings summaries

ACOG Stock 12 Month Forecast

Average Price Target

$20.00

▲(106.19% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","18":"$18","33":"$33","10.5":"$10.5","25.5":"$25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,10.5,18,25.5,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2021","6":"Oct<br/>2021","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.2,10.03076923076923,10.86153846153846,11.692307692307692,12.523076923076923,13.353846153846153,14.184615384615384,15.015384615384615,15.846153846153847,16.676923076923075,17.50769230769231,18.338461538461537,19.16923076923077,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.2,10.03076923076923,10.86153846153846,11.692307692307692,12.523076923076923,13.353846153846153,14.184615384615384,15.015384615384615,15.846153846153847,16.676923076923075,17.50769230769231,18.338461538461537,19.16923076923077,{"y":20,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.2,10.03076923076923,10.86153846153846,11.692307692307692,12.523076923076923,13.353846153846153,14.184615384615384,15.015384615384615,15.846153846153847,16.676923076923075,17.50769230769231,18.338461538461537,19.16923076923077,{"y":20,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.75,"date":1619827200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.75,"date":1622505600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.75,"date":1625097600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20,"date":1627776000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.5,"date":1630454400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.5,"date":1630454400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1633046400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.36,"date":1651363200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.01,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.85,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.98,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.74,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >